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Borstel, Freising, and Luebeck, GermanyBackground: Peanut is one of the most hazardous sources of
food allergens. Unknown allergens are still hidden in the
complex lipophilic matrix. These allergens need to be discovered
to allow estimation of the allergenic risk for patients with
peanut allergy and to further improve diagnostic measures.
Objective: We performed detection, isolation, and
characterization of novel peanut allergens from lipophilic
peanut extract.
Methods: Extraction of roasted peanuts were performed under
defined extraction conditions and examined by means of
2-dimensional PAGE. Subsequently, chromatographic methods
were adapted to isolate low-molecular-weight components.
Proteins were studied by using SDS-PAGE and immunoblotting
with sera from patients with peanut allergy. For allergen
identification protein sequencing, homology search and mass
spectrometry were applied. Functional characterization for
allergenicity was performed by using the basophil activation
assay and for antimicrobial activity by using inhibition assays of
different bacteria and fungi.
Results: IgE-reactive proteins of 12, 11, and 10 kDa were first
detected after chloroform/methanol extraction in the flow
through of hydrophobic interaction chromatography. The
proteins were able to activate basophils of patients with peanut
allergy. N-terminal sequencing and homology search in the
expressed sequence tag database identified the allergens as
peanut defensins, which was confirmed by using mass
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Conclusions: We identified defensins as novel peanut allergens
(Ara h 12 and Ara h 13) that react in particular with IgE of
patients with severe peanut allergy. Their antimicrobial
activity is solely antifungal. (J Allergy Clin Immunol
2015;136:1295-301.)
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Peanut is one of the most hazardous sources of food allergens.
As little as 100 mg of peanut protein can provoke symptoms in
allergic subjects.1 In the majority of cases, the symptoms of
peanut allergy are severe; some are even fatal. One percent of
the US population is affected by peanut allergy, and the
prevalence is increasing,2 especially in US and European
children.3 However, it is difficult to avoid peanuts because they
can be present as hidden allergens in exotic meals, in candy
bars, and as supplements, such as peanut oil in cosmetics.
The reason for the strong allergenicity of peanut is due to many
factors, such as the molecular complexity of peanuts, the high lipid
content, and some effects of food processing on peanut proteins4
(ie, dry roasting of peanuts or roasting them in oil for variable times
and temperatures5,6 has been shown to increase allergenicity).
As of June 2012, 10 peanut allergens had been listed in the
allergen database of the World Health Organization/International
Union of Immunological Societies. The allergens were usually
isolated by use of aqueous buffers and at neutral pH, which is
similar to the preparation of routine diagnostic extracts. Becker7
demonstrated that the protein and allergen patterns of peanut can
vary considerably as a function of the pH value of the extraction
buffer. Because of the high lipid content of up to 50%,8 lipophilic
allergens might not be included in aqueous extracts.9 For example,
Leduc et al10 reported that 10 of 34 patients with sesame allergy re-
mained unidentified because key lipophilic allergens, such as oleo-
sins, were not included in the aqueous diagnostic extract. The lipid
phase of food extracts has thus far only partially been characterized
for allergens.8 However, peanut contains several lipophilic aller-
gens, such as Ara h 9, a lipid transfer protein, and Ara h 10 and
11, both oleosins. Recently, Ara h 8, the Bet v 1 homologue natu-
rally associated with lipids, was isolated efficiently by means of
chloroform/methanol extraction under alkaline conditions.11
Importantly, increased IgE reactivity, aswell as thermal and proteo-
lytic stability as a function of roasting conditions and/or lipid asso-
ciation, was observed for Ara h 8.
In the process of purifying the lipid-associated Ara h 8,
additional low-molecular-weight and thus far previously
unidentified IgE-reactive peanut proteins became visible.
Therefore we focused on identification and allergenic and1295
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lipophilic extracts. Inclusion of lipophilic allergens potentially
improves the sensitivity and specificity of aqueous extract–based
diagnostics. Risk assessment and management of peanut allergy
can be improved by the availability of comprehensive individual
sensitization patterns facilitated by the characterization of these
novel allergens (ie, by expanding the repertoire of relevant
allergens in component-resolved diagnostics).METHODS
Isolation of peanut defensin
Roasted peanuts (Seeberger Riesen; Seeberger, Ulm, Germany) were peeled
and ground, and lipophilic extractionwas performed, as previously described.11
Briefly, peanut flour (1:8wt/vol) was dispersed in 50mmol/L sodium carbonate
(pH 11) for 1 hour at room temperature, chloroform/methanol (5:4 vol/vol) was
added, and the mixture was centrifuged to separate from solid material. The
organic solvent was removed from the aqueous phase by means of rotary evap-
oration, and the extract was dialyzed with Milli-Q water (Millipore, Temecula,
Calif) overnight at room temperature.
After extraction, chromatographic separation was performed on an
€AKTAprime device (GE Healthcare, Freiburg, Germany). Hydrophobic inter-
action chromatography (Phenyl Sepharose High Performance, GE Healthcare)
was accomplished with 1 mol/L ammonium sulfate, and the flow through was
concentrated 10-fold for subsequent gel filtration (Superdex 75 and Superdex
Peptide,GEHealthcare).After dialysis, final purificationwas achievedbymeans
of cation exchange chromatography (Source S, GE Healthcare).Sera
Sera from patients with peanut allergy, from allergic patients without
peanut allergy, and from nonallergic, nonsensitized healthy subjects were
included in this study after obtaining informed consent. For detailed
characterization, see Table I and Table E1 in this article’s Online Repository
at www.jacionline.org. The patients refused to have challenge tests with foods
to which they knew themselves to be allergic. The sera of patients with allergy
but not peanut allergy and nonallergic, nonsensitized healthy subjects were
used as negative controls. The study was approved by the respective local
ethics committee (approval no. 10-126).SDS-PAGE, Western blotting, 2-dimensional PAGE,
protein sequencing, and mass spectrometry
For detailed information, see the Methods section in this article’s Online
Repository at www.jacionline.org.Basophil activation test
Basophil activation was determined through expression of CD203c, as
previously described, with modifications.12 Briefly, 100 mL of heparinized
whole-blood aliquots of patients with peanut allergy were stimulated with
purified allergens in 10-fold serial dilutions starting with 5400 ng/mL and
incubated for 20 minutes at 378C. Nonstimulated cells served as negative con-
trols, and cells stimulated with formyl-methionyl-leucyl-phenylalanine
(Sigma-Aldrich, Steinheim, Germany) or zymosan (Sigma-Aldrich) served as
positive controls. Afterward, 5 mL of phycoerythrin-conjugated anti-CD203c
(Immunotech, Marseille, France) was added to each sample and incubated for
an additional 20 minutes at 258C. Red blood cells were lysed by addition of2 mL of Quicklysis solution (Medac, Wedel, Germany). After centrifugation
(640g for 6 minutes), cells were resuspended in 150 mL of PBS/0.1% azide
and 100 mL of 3% paraformaldehyde. Measurements were performed on a
flow cytometer (FACSCalibur; BD Biosciences, San Jose, Calif). The mean
fluorescence intensity of CD203c on basophils was determined by using FCS
Express 4.0 (De Novo Software, Los Angeles, Calif).Microbial inhibition assays
Antifungal activity assay. Antifungal activity was measured by
using a microspectrometric assay, according to the method of Cammue et al.13
Eighty microliters of fungal spore suspension (23 104 spores/mL) consisting
of Candida albicans, Saccharomyces cerevisiae, Pichia pastoris, Fusarium
culmorum, Alternaria species, Cladosporium species, Aspergillus flavus,
and 20 mL of the synthetic fungal growth medium was supplemented with
defined concentrations of peanut defensin on amicroplate (final concentration,
0-100mg/mL). Cultures were incubated for up to 168 hours at a temperature of
228C. Density measurements were performed at different time points at
570 nm by using a microplate Dynex MRX Revelation Microplate Reader
(MTX Lab Systems, Vienna, Va). Percentage growth inhibition was defined
as 100 times the ratio of the corrected absorbance of the control microculture
minus the corrected absorbance of the test microculture over the corrected
absorbance of the control microculture.
Antibacterial activity assay. Microsusceptibility analysis was
performed todetermine theminimal inhibitory concentrationof the tested peanut
defensins (up to a concentration of 64 mg/mL) against bacteria of the strains
Escherichia coliWBB01andStaphylococcusaureus (clinical isolate).A96-well
flat-bottommicrotiter plate (Corning,Corning,NY)waspreparedwith thebuffer
(20mmol/L HEPES, pH 5.2 and pH 7.4) and serial peptide dilutions to be tested
(90 mL). Finally, 10 mL of the bacterial suspension (1 3 106 colony-forming
units$mL21) in LB broth was added to all but the negative control. Buffer and
bacterial suspension served as a positive control, and buffer and growthmedium
served as a negative control. After incubation at 378C and 150 rpm, overnight
density measurements of the microtiter plates were carried out after 20 hours
of inoculation with an ELISA reader (Rainbow; Tecan, Crailsheim, Germany)
at 620 nm. The minimal inhibitory concentration was determined as the peptide
concentration at which no culture growth was detected.
RESULTS
Detection and isolation of novel peanut allergens
To detect and isolate allergens in the low-molecular-weight
range of peanut extract, we used the protocol for the isolation of
Ara h 8 from lipophilic extraction under alkaline conditions.
When we removed the contaminants by using hydrophobic
interaction chromatography, we identified in the flow through
some known peanut allergens, such as Ara h 2. Additionally, an
intensive protein spot of about 8 kDa and an isoelectric point of
7.7 to 8.1 was detectable by using 2-dimensional PAGE under
reducing conditions (Fig 1).Immunologic characterization
SDS-PAGE was performed under nonreducing and reducing
conditions to identify and characterize the isolated proteins
(Fig 2, A). Fig 2, A, shows that 3 bands of about 10, 11, and
12 kDa were detectable under nonreducing conditions, whereas
under reducing conditions, only 1 band appeared, with a
molecular mass of about 8 kDa.
The isolated components were analyzed for IgE reactivity by
using Western blotting. Sera of patients with peanut
allergy, patients with allergy but not peanut allergy, and
nonallergic, nonsensitized healthy subjects were screened for
IgE reactivity to the proteins separated under nonreducing and
reducing conditions.
TABLE I. Clinical data of patients with peanut allergy
Patient ID Sex Age (y)
Total IgE
(IU/mL)
Specific IgE through ImmunoCAP to:
Symptoms
Peanut extract
(kU/L)
Ara h 2
(kU/L)
Ara h 8
(kU/L)
P1 M 47 508 >100 60.5 17.3 Anaphylactic shock in childhood, cardiac symptoms after
ingestion of low peanut concentrations
P2 M 14 732 >100 96.5 0.09 Vomiting, urticaria, problems breathing through the nose,
tussive irritation, contact urticaria
P3 F 5 367 71.0 41.0 0.1 No ingestion, skin contact/ worsening of atopic eczema
P4 F 21 1828 47.50 28.9 11.4 Swelling of mucosa of mouth, throat, and larynx;
swallowing problems; dyspnea; hypotonia; tremor
P5 M 42 175 32.9 18.9 0.1 After mere contact: contact urticaria with subsequent OAS,
laryngeal edema, maximal fatigue, dyspnea
P6 M 41 555 19.5 1.15 0 Facial edema, dyspnea, urticaria
P7 M 12 22.1 0 0 0 OAS to peanut and seasonal rhinoconjunctivitis
P8 F 35 72.1 0.51 0 7.46 Itching of throat, difficulties in breathing after ingestion
of fresh peanuts
P9 F 38 793.1 5.75 1.17 9.16 OAS to peanut and seasonal rhinoconjunctivitis
P10 F 23 689.7 1.66 0 13.30 OAS to peanut and seasonal rhinoconjunctivitis
P11 M 27 536 75.9 150.0 6.13 Anaphylactic symptoms, angioedema, larynx edema, flush,
generalized urticaria, dyspnea, absence
P* F 51 2.0 0 0 0 No allergic symptoms
F, Female; M, male; OAS, oral allergy syndrome; P*, control subject.
FIG 1. Two-dimensional PAGE of hydrophobic interaction chromatography
flow through of the lipophilic peanut extract. Separation was performed
under reducing conditions and Coomassie stained. The protein spot under
consideration is indicated.M, Molecular mass marker; pI, isoelectric point.
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to Table I) show strong clear bands, whereas patient P9 shows
only weak bands in the range of 10 to 12 kDa. Patients P1 and
P5 react only weakly to one of the 3 bands. Additional control
sera (P14-P25) showed no IgE reactivity under nonreducing
conditions (see Fig E1 in this article’s Online Repository at
www.jacionline.org). Interestingly, most of the reactive sera
were obtained from patients with severe anaphylactic reactions
to peanut. The positive sera recognized the 3 proteins with
different intensities, although the upper of the 3 protein bands is
the most prominent. However, staining with India ink did not
detect any protein band in the nonreduced and reduced sample
(see Fig 2, B and C, and Fig E1, lane I). Interestingly, only one
of the 6 positive patient sera (P2) bound under reducing condi-
tions (Fig 2, C). The results demonstrate that the isolated proteins
are IgE reactive but lose their IgE-binding capacity on reduction.Functional tests
Whole-blood samples of 12 patients were selected to perform
the CD203c basophil activation test, a test acknowledged as afunctional assay for allergenicity, to determine whether the
IgE-reactive proteins can elicit histamine release.14
Fig 3 depicts the results of the sera (patients P1, P3, P5,
and P11) studied with a serial dilution of the allergen
(0.0054-5400 mg/mL). Although basophil activation for patients
P1, P3, P5, and P11, as well as for patients P12 and P13 (see
Fig E2 in this article’s Online Repository at www.jacionline.
org), was detectable, no basophil activation was observed for
patients P17, P20, P21, P22, P23, and P* (see Fig E2).
In parallel, we cultivated several bacterial and fungal species
with the peanut defensins and determined the relative inhibition
on microbial growth after different time intervals. The bacterial
strains E coli WBB01 as an example of gram-negative and
Staphylococcus aureus as an example of gram-positive bacteria
showed no effect on the addition of up to 64 mg/mL peanut
defensins, which is similar to the yeasts C albicans, P pastoris,
and S cerevisiae (data not shown).
In contrast, as shown in Fig 4, a dose-dependent effect was
observed for the mold species Alternaria and Cladosporium: low
concentrations (6.25 mg/mL) caused a slight effect or even, in
the case ofAlternaria species, an increase in growth during the first
24 hours of culture, whereas 25 to 100 mg/mL of the peanut defen-
sin showed a prolonged inhibitory effect on fungal growth of about
70% with Alternaria and Cladosporium species. For F culmorum
and A flavus, slightly decreased cell growth was detectable only
during the first 24 to 48 hours of culture (data not shown).Biochemical and physicochemical characterization
Protein bands III (12 kDa), I (11 kDa), and II (10 kDa), as
shown in Fig 2, A, were further analyzed by means of protein
sequencing, and the 17 N-terminal amino acids were determined.
Fig 5 summarizes the results obtained from protein sequencing,
homology screening, and mass spectrometric analysis.
Searching for homologous proteins in the National Center for
Biotechnology Information protein database was not successful.
FIG 2. A, SDS-PAGE of the isolated protein fraction separated under reducing (R) and nonreducing (N)
conditionswith Coomassie staining. B and C, Western blots for identification of IgE-reactive sera from patients
with peanut allergy under nonreducing (Fig 2,B) and reducing (Fig 2,C) conditions.C, Buffer control; I, India ink
staining;M, molecular mass marker; P, patients’ sera (numbers as listed in Table I); P*, nonallergic subject.
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and deducing the amino acid sequence from the DNA data, we
found complete identity with the sequences of the peanut defensins
(except the cysteine residues in amino acid positions 3 and 14 that
are not determinable by using Edman degradation).
The 12-kDa band referred to accession number EY396089, the
11-kDa band referred to accession number EY396019, and the
10-kDa protein referred to accession number EE124955.
Although the first 2 proteins were very similar among each other,
with only 3 amino acid exchanges, the last sequence, EY396089,
differed by 27 amino acids (43% sequence identity; Fig 5, A).
Additionally, the masses of the isolated intact proteins were
determined by using high-resolution mass spectrometry and
compared with the calculated masses (Fig 5).
The spectrum shows 5 main peaks with monoisotopic
molecular masses of 5184.1, 5200.0, 5216.1, 5442.4, and
5472.4 Da. The peaks marked as I, II, and III showed in each
case an 8-Da lower mass than calculated. The masses correspond-
ing to peaks IVand V were 16 Da and 32 Da higher than peak III.
Furthermore, tryptic mass fingerprinting was performed with
the 3 bands from the gel run under nonreducing conditions to
confirm the data. The tryptic fragments correspond with the
respective sequences that are highlighted in gray in Fig 5, A. The
percentages of sequence coverage are 46.8% for EY396019 and
EE124955 and 73.9% for EY396089.
A sequence alignment of the peanut defensins and several
selected other plant defensins are shown in Fig E3 in this article’s
Online Repository at www.jacionline.org.DISCUSSION
Occasionally, the clinical diagnosis of peanut allergy cannot be
confirmed by means of extract-based IgE detection and ascribedto known allergens, which indicates the necessity to improve
in vitro diagnostic procedures. In the process of purifying Ara h 8
for use in investigations of whether lipid association renders
Ara h 8 resistant to temperature and digestion,11 additional
low-molecular-weight and hitherto unidentified IgE-reactive
peanut proteins became visible. We pursued the identification
and functional characterization of these novel allergens because
other sources have shown lipophilic allergens to be clinically
relevant and even associatedwith severe reactions but nonetheless
still lacking in routine allergy diagnostic extracts.
The lipophilic extraction strategy was successful in identifying
2 novel allergens and 1 additional isoform in peanuts. They
belong to pathogenesis-related protein family 12, the plant
defensins.15 Pathogenesis-related proteins are characterized by
the fact that they are synthesized particularly under stress
conditions. Our data were submitted to the World Health
Organization/International Union of Immunological Societies
allergen nomenclature subcommittee, and the peanut allergens
were classified as Ara h 12 and 13.
Defensins are small amphiphilic cationic proteins found in
plants, invertebrates, and vertebrates.16 The primary structure of
plant defensins is divergent, but plant defensins share common
structural characteristics,17 such as the conserved cysteine spacing
pattern and the formation of 4 disulfide bonds between C1-C8,
C2-C5, C3-C6, and C4-C7.18 The obtained 3-dimensional
structures are similar to those of a triple-strand anti-parallel
b-sheet and one a-helix as characterized on Rs-AFP2, which
serves as a model defensin.19 The same structural elements can
be found in insect defensins and scorpion toxins.17,20
We detected the peanut defensins in the low-molecular-weight
range after separation from the hydrophobic proteins found in a
lipophilic peanut extract at alkaline pH. This fractionation
resulted in the protein pattern shown in Fig 1.
FIG 3. The basophil activation test (CD203c) was performed in blood samples of 4 patients with peanut
allergy. Blood samples were stimulated with 0.0054 to 5400 mg/L peanut defensin or 4.37 to 437.55 mg/L
formyl-methionyl-leucyl-phenylalanine (fMLP) as a positive control. For unstimulated samples, PBS was
used. MFI, Mean fluorescence intensity; PE, phycoerythrin.
FIG 4. Determination of antifungal activity by using a growth inhibition assay
of different fungal species analyzed in the presence of the peanut defensin.
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sequencing and mass spectrometry and resulted in the
identification of 2 groups of peanut defensins with sequence
identities of only 43% to 45%. The protein masses calculatedfrom the EST sequences were exactly 8 mass units higher than the
masses determined for the 3 proteins of the isolated fraction. This
suggests the formation of 4 disulfide bonds resulting from the loss
of 8 hydrogen atoms. Furthermore, the existence of these defensin
molecules in the plant was clearly confirmed by the peptides
identified by means of tryptic mass fingerprinting. Although a
putative N-glycosylation site is predicted for the sequence of Ara
h 12 and Ara h 13, our mass spectrometric results prove that the
defensins are not glycosylated, which is in accordance with the
literature.
The analysis of Ara h 12 revealed 3 molecular peaks that
differed by 16 mass units each. A probable explanation for this is
the oxidation of methionine to methionine sulfoxide,21 which
causes an increase of 16 mass units. Ara h 12 contains 2
methionine residues, and thus (besides the nonoxidized form of
5184.1 Da) the masses of 5216.1 Da and 5200.0 Da might be
elicited by different numbers of oxidized methionines. In the
analysis of Ara h 13, we identified 2 isoforms referring to
the EST sequences EY396019 and EE124955. The isoforms
differ by 3 amino acids (E2V, S17T, and K46N).
FIG 5. A, Comparison of the 3 peanut defensins detected by using SDS-PAGE under nonreducing
conditions. Complete protein sequences were deduced from the EST database. N-terminal protein
sequences are underlined. Sequence comparison is presented as identity in percentages. Tryptic peptide
fragments were analyzed by using matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry and are highlighted in gray. MW, Molecular weight. B, Electrospray ionization–Fourier
transform ion cyclotron resonance mass spectrum of the isolated protein fraction. Monoisotopic neutral
masses are indicated.
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migratory behavior in SDS-PAGE. The molecular mass appears
to be higher under nonreducing conditions (10, 11, and 12 kDa)
than under reducing conditions (8 kDa). Because of disulfide
formations, a more compact structure with smaller apparent size
could be assumed. However, the peanut defensins probably form
dimers under natural conditions similar to what has been
described for a tobacco defensin.18 Dimerization might also be
the reason that the small molecules are able to cross-link
surface-bound IgE and activate basophils. In addition, we
observed no IgE reactivity in Western blot analysis for sera
from patients P11, P12, and P13, but we did observe basophil
activation after stimulation with defensins. This might be due to
the fact that the sensitivity of the basophil activation test is higher
than that of serum IgE detection in the Western blot.22,23 Taking
into account that the conformation of the defensins is critical for
IgE detection, some epitopes might not be detectable in Western
blot analysis, resulting in loss of IgE recognition.
IgE reactivity to the peanut defensins was detected in particular
in sera from patients with severe anaphylactic reactions to peanut.
Studies are already in progress to elucidate whether peanut
defensins can be considered marker allergens for severe peanut
allergy, as suggested by our preliminary results.
To date, only 3 defensin-related proteins have been described
as allergens. Two pollen allergens with a defensin-like domain
have already been described in the published literature, Art v 1
from mugwort and Amb a 4 from ragweed.24,25 These proteins
consist of a 57-amino-acid N-terminal defensin-like domain anda C-terminal, proline-rich, highly glycosylated part of 52 amino
acid residues. Thus IgE reactivity cannot be ascribed solely to
the defensin part. Additionally, an 8-kDa protein was detected
in soybean hull dust that was associated with respiratory
symptoms in exposed allergic workers.26 The N-terminus of 19
amino acids was determined and showed similarity to defensins.
Many other plant defensins have been described, and their
sequences are available in databases, but they have not been
investigated in relation to allergy. Of all these defensins, Ara h
12 showed the highest sequence similarity to the pea protein
Psd1,27 with 72% identity, and Ara h 13.0101 showed the highest
sequence similarity to theVicia faba protein ACI02060, with 70%
identity.
Because of the specific defensin structure, the loss of the
disulfide formations is probably the reason for the lack of IgE
reactivity of the peanut defensins under reducing conditions.
However, the disulfide bonds are responsible for the stability of
defensins regarding pH changes, proteolytic digestion by trypsin,
and extreme temperature changes.28 These features might be
modulating factors for immunogenicity and could add to the
allergenicity of peanut defensins.
Because we discovered that the 2 novel peanut allergens were
plant defensins, we were interested in their effect on microbes.
Defensins are widely distributed host defense peptides that
mainly exhibit antimicrobial activity directed against bacteria,
fungi, and viruses. Defensins in seeds of leguminous plants
(Fabaceae; eg, peanuts and beans) are part of their innate immune
response together with other antimicrobial peptides, such as lipid
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and lectins,28 some of which are already known to be allergens as
well. Most of the Fabaceae-derived defensins show antifungal
activity, which is why the investigation of the antimicrobial
activity of the peanut defensins started along that line.
A clear growth inhibition of the fungal species Alternaria and
Cladosporium was demonstrated. These results reflect the real
situation with the natural mixture of different peanut defensins.
Our observations corroborate the results of other research
groups,29,30 who have also described antifungal activity of
plant defensins on Alternaria and Cladosporium species.
Garcia-Olmedo et al31 and Stotz et al32 summarize that plant
defensins show mostly antifungal activity, whereas lipid transfer
proteins are directed against bacteria. Together, these 2 groups of
defense proteins form a general barrier against pathogens.
The mechanism through which defensins act is not completely
understood. Because of many cationic and hydrophobic amino
acids, the defensins can attach to negatively charged membranes.
Different groups of defensins can act together.
We were able to identify 2 novel peanut allergens that in our
group of patients are IgE reactive, particularly in sera of patients
with severe peanut allergy. In addition, we could show antifungal
but not antibacterial activity of the peanut defensins. With regard
to human subjects, the peanut defensins are a double-edged
sword: on the one hand, the antimicrobial effect could be
beneficial when patients with atopic dermatitis apply peanut
oil–based ointments, but on the other hand, the defensins are
allergens possibly associated with severe peanut allergy and are
also small enough to penetrate the epidermal barrier, as is known
to be the case for other peanut allergens.
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Clinical implications: Peanut defensins are identified as novel
allergens (Ara h 12 and 13) and recognized in particular by
patients with severe reactions. They were shown to elicit
antifungal but not antibacterial activity.REFERENCES
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METHODS
SDS-PAGE and Western blotting
SDS-PAGEwas performed according to themethod of LaemmliE1 by using
the XCELL Mini Cell System (Novex, San Diego, Calif) with 4-12% or 12%
acrylamide Bis-Tris gels. After protein separation, gels were fixed for
30 minutes in 5% glutaraldehyde and afterward stained with 0.2% Coomassie
Brilliant Blue G-250 (Serva, Heidelberg, Germany).
For immunoblot analysis, proteins were transferred to polyvinylidene
fluoride (PVDF) membranes (Millipore, Schwalbach, Germany) by means
of semidry blotting for 45 minutes at 0.8 mA/cm2, as described
previously.E2 Membranes were blocked with 5% skimmed milk powder
in Tris-buffered saline with Tween 20 (TTBS; 100 mmol/L Tris,
100 mmol/L NaCl, 2.5 mmol/L MgCl2, and 0.05% Tween 20 [pH 7.4])
overnight. Patients’ sera were diluted 1:10 with 2.5% skimmed milk
powder in TTBS and incubated overnight. Bound antibodies were
detected by using a horseradish peroxidase–conjugated secondary
antibody, mouse anti-human IgE (Fc)–horseradish peroxidase (1:5000;
Southern Biotech, Birmingham, Ala) diluted in TTBS for 2 hours.
Immunostaining was performed applying chemiluminescent Western blot
detection with Clarity Western ECL Substrate (Bio-Rad Laboratories,
Hercules, Calif). Stained blots were detected with the ChemiDoc MP
System (Bio-Rad Laboratories). Protein staining on PVDF membranes
was accomplished by using India ink (Winsor and Newton, London,
United Kingdom) at a dilution of 1:1000 in TTBS for 2 hoursE3 or
staining with 10% trichloroethanol (Sigma-Aldrich) in 1:1 (vol/vol)
water/methanol.E4
Two-dimensional PAGE
Two-dimensional electrophoresis was performed, as previously described,
with slight modifications.E5 Briefly, immobilized pH gradient strips 3-10
(Novex IPG Zoom Strips; Invitrogen, Groningen, The Netherlands) were
used for separation in the first dimension (isoelectric focusing). About
100 mg of peanut extract was loaded per gel strip, and the separation was per-
formed at 2 mA and 2 W, with increasing voltage at 200 V for 20 minutes,
450 V for 15 minutes, 750 V for 15 minutes, and 2000 V for 1 hour. SDS-
PAGE was carried out at 200 Vand 30 mA in the second dimension by using
4-12% acrylamide gradient Bis-Tris gels (Invitrogen). After protein separa-
tion, gels were fixed for 30 minutes in 5% glutaraldehyde.
Molecular masses and isoelectric points were determined by comparison
with spectra multicolor low-range protein standard (1.7-40 kDa; Thermo
Scientific, Vilnius, Lithuania) and Isoelectric Focusing Marker 3-10, Liquid
Mix (Serva). Afterward, the gels were Coomassie stained or blotted onto
PVDF membrane and immunostained.
Protein sequencing
After blotting, the PVDF membrane was washed with Milli-Q water,
stained with 0.1% Coomassie in 50% methanol, destained in 50% methanol,
and air-dried. Protein bands were excised, and microsequencing was
performed on a Procise protein sequencer with an online phenylthiohydantoin
amino acid analyzer (PE Biosystems, Weiterstadt, Germany).E6
Mass spectrometry
Themasses of the protein fractionwere analyzed by using a high-resolution
electrospray ionization (ESI) Fourier transform ion cyclotron resonance mass
spectrometer (APEX-Qe; Bruker Daltonics, Billerica, Mass) equipped with a
7 Tesla actively shielded magnet and an Apollo ion source.E7 The lyophilized
proteins were dissolved in a 50:50:0.001 (vol/vol/vol) mixture of methanol,
water, and acetic acid and sprayed with a flow rate of 2 mL/min. For a
straightforward interpretation of the heterogeneous samples, the obtained
positive ion mass spectra were charge deconvoluted. Mass numbers refer to
the monoisotopic mass of the neutral molecules.
Tryptic mass fingerprinting was performed, as described previously.E7
Briefly,Coomassie-stainedproteinbandswereexcised,destained, anddigested
overnight with trypsin (Trypsin Gold, Mass Spectrometry Grade; Promega,
Mannheim, Germany), as described previously.E8 Afterward, the corresponding
tryptic fragments were mixed 1:1 (vol/vol) with saturated a-cyano-4-
hydroxycinnamic acid matrix solution (Bruker Daltonics, Bremen, Germany)
and spotted on the target. The samples were analyzed with a Reflex III (Bruker
Daltonics) in reflector mode applying an acceleration voltage of 20 kV. External
mass calibration was performed with an appropriate mixture of peptides.
Mass spectrometric data were analyzed with BioTools 2.0 (Bruker Daltonics).
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FIG E1. Western blot experiments with 14 additional subjects (for
characterization, see Table E1) under nonreducing conditions.E4 C, Buffer
control; I, India ink staining; M, molecular mass marker; P, patients’
sera (numbers are as listed in Table E1); P4, positive control patient (see
Table I); TCE, protein staining with trichloroethanol.
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FIG E2. Additional basophil activation tests (CD203c) were performed with 2 patients with peanut allergy, 5
patients with allergy but not peanut allergy, and 1 nonallergic nonsensitized subject. Blood samples were
stimulated with 0.0054 to 5,400 mg/L peanut defensin or 4.37 to 437.55 mg/L formyl-methionyl-leucyl-
phenylalanine (fMLP) or 5,000 to 500,000 mg/L zymosan as a positive control. For unstimulated samples,
PBS was used. MFI, Mean fluorescence intensity; PE, phycoerythrin.
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FIG E3. Sequence alignment of selected plant defensins. Rs-AFP2 is the radish (Raphanus sativus) plant
defensin.E9 Defensins from the Leguminosae include Ara h 12-13 (peanut defensins), pea (Pisum sativum),
Gly m 2 fromGlycinemaxima (only theN-terminal sequence is knownE10). Plant allergens with defensin-like
domains include Art v 1 from Artemisia vulgarisE11 and Amb a 4 from Ambrosia artemisiifolia.E12 Amino
acids conserved in plant defensins are indicated in red; mostly conserved amino acids are in blue.
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TABLE E1. Clinical data of additional patients with peanut allergy and control subjects
Patient ID Sex Age (y)
Total IgE
(IU/mL)
Specific IgE through ImmunoCAP to:
Symptoms
Peanut extract
(kU/L)
Ara h 2
(kU/L)
Ara h 8
(kU/L)
P12 M 19 260.00 66.30 22.00 1.79 Dyspnea, flush, conjunctivitis, facial edema
P13 F 24 92.70 18.0 14.0 4.08 Generalized urticaria, massive generalized
itching, conjunctivitis
P14 F 37 281 1.03 0 2.91 Allergic, pollen-associated food allergy but
no symptoms after peanut consumption
P15 F 51 311.3 3.54 0.00 10.50 Pollen-associated food allergy but no symptoms
after peanut consumption
P16 F 21 128.1 2.31 0 10 Allergic, specific peanut IgE against peanut
extract and Ara h 8, no symptoms after consumption
P17 F 49 142 0.4 0 3.08 Allergic, specific peanut IgE against peanut
extract and Ara h 8, no symptoms after consumption
P18 M 26 49.3 0 0 5.07 Pollen-associated food allergy but no symptoms
after peanut consumption
P19 F 39 87.3 0 0 3.44 Pollen-associated food allergy but no symptoms
after peanut consumption
P20 F 30 138.5 0 0 8.48 Pollen-associated food allergy, specific peanut
IgE against Ara h 8, no definite allergic symptoms
after consumption (once minor perioral dermatitis
[minuscule papules], excluding the lips): suspected
irritant contact dermatitis
P21 F 47 46.10 0 0 1.4 Pollen-associated food allergy but not peanut allergy
(no symptoms after peanut consumption)
P22 F 59 161.9 0 0 4.84 Pollen-associated food allergy but no symptoms after
peanut consumption
P23 F 53 3.8 0 0 0 Allergic (eg, birch pollen allergy) but no symptoms
after peanut consumption
P24 M 70 11.9 0 0 0 No allergic symptoms
P25 M 47 5.2 0 0 0 No allergic symptoms
F, Female; M, male.
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